Skip to Content

Epoetin beta-methoxy polyethylene glycol Pregnancy and Breastfeeding Warnings

Epoetin beta-methoxy polyethylene glycol is also known as: Mircera

Medically reviewed on Sep 26, 2017

Epoetin beta-methoxy polyethylene glycol Pregnancy Warnings

Epoetin beta-methoxy polyethylene glycol has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of bone malformation, dose-related reduction in fetal weights, increased deaths, and significant reduction in growth rate. There are no controlled data in human pregnancy. Epoetin beta-methoxy polyethylene glycol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

See references

Epoetin beta-methoxy polyethylene glycol Breastfeeding Warnings

There are no data on the excretion of epoetin beta-methoxy polyethylene glycol into human milk. Because many drugs are excreted in human milk, the manufacturer recommends caution if epoetin beta-methoxy polyethylene glycol is administered to a nursing woman.

In one animal study, epoetin beta-methoxy polyethylene glycol was excreted into maternal milk.

See references

References for pregnancy information

  1. "Product Information. Mircera (epoetin beta-methoxy polyethylene glycol)." Roche Laboratories, Nutley, NJ.

References for breastfeeding information

  1. "Product Information. Mircera (epoetin beta-methoxy polyethylene glycol)." Roche Laboratories, Nutley, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide